Will Flexible Work be a Permanent Part of the Retail Landscape?

Designed for retail leaders and lovers alike, Retail Refined explores the in-store technology of the future, challenges the industry’s preconceived notions, and brings together retail’s biggest names to understand the brand strategies that will define the next decade in retail.

 

Flexible work schedules and work-life balance were a thing before the pandemic, but COVID-19 accelerated the work-from-home model. It also pushed it firmly into the public’s psyche that finding balance in the workplace should be a priority, particularly for women.

On this episode of Retail Refined, Host Melissa Gonzalez talked with Greg Hanover, CEO of Liveops, a leader and pioneer in the virtual contact center space. They have pushed the ideas of flexible workforces and crowdsourcing serving enterprise organizations in customer care and sales.

As the economy opens back up, companies are diligently looking for workers to meet the demand of a shopping boom. In anticipation of the boom, retailers added 16,000 jobs in March, but that’s only for physical stores. Retailers are also hiring for customer service roles, which allow more work-from-home and flexible opportunities. But, the role of the customer service agent has changed over the past 18 months.

“The role of the agent has really changed, especially in the retail space,” Hanover said. “You think about the growth in eCommerce and what’s happening in terms of offline vs. online shopping. Just the change in the customer experience that’s happening, where customers who may have traditionally gone into a brick-and-mortar store are now an eCommerce shopper.”

The challenge for retailers is recreating the in-person experience in an online model from a customer service perspective. Customer service agents also have to be sales agents because the experience they’re providing to a brick-and-mortar shopper has shifted.

Listen to Previous Episodes of Retail Refined Right Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More